[6] Gong X，Qin S.Study progression of anti-angiogenetic therapy and its combination with other agents for the treatment of advanced hepatocellular carcinoma[J].Hepatobiliary Surg Nutr，2018，7(6)：466-474.

    [7]潘運迎，杨得志，覃兴善，等.肠腺癌组织中CK7、CK20、CEA、Ki-67表达水平的临床病理意义[J].中国医学创新，2018，15(17)：144-148.

    [8] Siddiqui M T，Saboorian M H，Gokaslan S T，et al.Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples[J].Cancer ......